In Might 2019, a trial at Nanjing University Medical center commenced comparing dapagliflozin to liraglutide, and to the anti-diabetic medication acarbose, for their respective consequences on cognitive and olfactory perform in 87 overweight people today whose Type 2 diabetes is inadequately managed with metformin on your own. 知乎，让每一次点击都充满意义 —— 欢迎来到知乎，发现问题背后... https://billl666wis8.digitollblog.com/profile